scispace - formally typeset
Search or ask a question

Showing papers by "Hai-Rim Shin published in 2014"


Journal ArticleDOI
TL;DR: HPV was identified in a large proportion of invasive vaginal cancers and in almost all VAIN 2/3 and the most common type detected, HPV16 was the most frequently type detected in both precancerous and cancerous lesions.

145 citations


Journal ArticleDOI
TL;DR: This is an excerpt of the "Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014-2020)" (RAP NCD) which has been endorsed by the Member States of the Western Pacific Region of World Health Organization in October 2013.
Abstract: This is an excerpt of the "Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014-2020)" (RAP NCD) which has been endorsed by the Member States of the Western Pacific Region of World Health Organization in October 2013. The Regional plan is fully harmonized with the Global Action Plan for the Prevention and Control of Noncommunicable Diseases (2013-2020). The regional plan calls for a systematic approach to NCD prevention and control. The plan provides a road map and a menu of very cost-effective interventions for all Member States and other stakeholders, to take coordinated and coherent action at all levels to attain the nine voluntary global target by 2025. The original version of RAP NCD is downloadable from the website (http://www.wpro.who.int/noncommunicable_diseases/WHO_NCD_RAP.pdf?ua=1) In addition, there are NCD tools in the WHO homepage (http://www.who.int/nmh/ncd-tools/en/). Hai-Rim Shin, MD, PhD and Cherian Varghese, M.D., Ph.D. Noncommunicable Diseases and Health Promotion Unit, WHO Western Pacific Regional Office, Manila ([email protected]/* */). Language: en

83 citations


Journal ArticleDOI
TL;DR: St strengthening cancer registration, tobacco control, and promotion of a healthy diet, as well as HBV and HPV vaccination, is the priority areas to reduce cancer burden in LMICs and Pacific Island countries.
Abstract: Background Cancer has become a priority public health challenge in the Member States of the World Health Organization’s (WHO) Western Pacific Region (WPR). Rapid and unplanned urbanization, demographic transition, and lifestyle changes are driving the increase in noncommunicable diseases (NCDs), which include cancer. The WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020, targets a reduction in premature mortality from NCDs by 25% by 2025. Objectives The aim of this study was to review the epidemiology of cancer including cancer control efforts in the WPR. Methods Information was primarily extracted from Globocan 2012, Cancer Incidence in Five Continents Vol. X , and the NCD country capacity survey carried out by the WHO in 2013. The WPR, with one-fourth of the world’s population, has one-third of all cancers globally. Cancer cases in the WPR are expected to increase from 4.5 million new cases in 2012 to 6.4 million in 2025. Findings In most of the low- and middle-income countries (LMICs) in Asia and in Pacific Island countries and areas, coverage of cancer registration is relatively low and they face many challenges in quality of cancer registry data. Eighty-five percent of LMICs have indicated the existence of a cancer control policy strategy and/or action plan. The predominance of lung, stomach, colorectal, breast, and cervical cancers makes control of the disease more amenable in the WPR. A relatively high ratio of mortality to incidence in LMICs reflects health-system limitations, especially in the diagnosis and management of cancer. Conclusions Strengthening cancer registration, tobacco control, and promotion of a healthy diet, as well as HBV and HPV vaccination, is the priority areas to reduce cancer burden. Health-system strengthening with a defined package of services at different levels, referral care, trained human resources, and appropriate technology is necessary to improve cancer management. Pain relief and palliative care are priorities as well. A well-planned national cancer control program with a strong component of surveillance and monitoring can help to reduce the cancer burden in LMICs and Pacific Island countries.

45 citations



01 Jan 2014
TL;DR: China can further strengthen the comprehensive approach to risk-factor reduction through these interventions and expand early detection and management of cancer through a set of very cost-eff ective interventions, as suggested by the global and regional action plans for non-communicable diseases.
Abstract: www.thelancet.com/oncology Vol 15 April 2014 485 through a set of very cost-eff ective interventions, as suggested by the global and regional action plans for non-communicable diseases. In collaboration with the Government of China, a focused approach has been initiated in the provinces of Chongqing, Guanxi, and Shanxi to strengthen the prevention and control of non-communicable diseases (including cancer control) under the Western Area Health Initiative. Tobacco control is a priority for WHO and China is working towards control of tobacco products through legislation and regulation. The WHO Regional Offi ce for the Western Pacifi c is working with the National Patriotic Health Campaign Committee in China to expand and scale up healthy cities as a platform for many interventions, including reduction of environmental pollution. The WHO Regional Offi ce for the Western Pacifi c has developed programmes for leadership in cancer control (eg, CanLEAD), and off ers country-specifi c support for registration, screening, and palliative care for cancer. A set of very cost-eff ective interventions are provided in the Global Action Plan to reduce tobacco and harmful alcohol use, improve unhealthy diets, and increase physical activity. These measures are mostly regulatory, legal, and fi scal interventions, and will aff ect rates of non-communicable diseases (including cancer) in large populations. China can further strengthen the comprehensive approach to risk-factor reduction through these interventions and expand early detection and management of cancer. Widespread coverage of vaccines for hepatitis B and human papillomavirus can help to further reduce infection-related cancers. A nationally representative cancer registry with improved quality and coverage will help to identify priorities and to track the progress of cancer control in China.